N2E-10737-62920
3 vaccinations
1 coded response
26 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 462 / IN
- Registered
- 2021-01-03
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-03
Registered in v-safe
-
2021-01-03
Dose 1 — Pfizer-BioNTech
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-07
- 2021-01-09
- 2021-01-10
- 2021-01-17
-
2021-01-24
Dose 2 — Pfizer-BioNTech
- 2021-02-22
- 2021-02-28
- 2021-03-07
- 2021-04-25
- 2021-07-25
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-02
- 2021-10-03
- 2021-10-04
- 2021-10-05
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-25
- 2021-11-13
-
2022-01-01
Survey response — 3 months, dose 3MedDRA: Cough, Oropharyngeal pain — Feeling: FairFree text: Sore throat and coughMedDRA releases: 2024-11 · check-in free text available
- 2022-04-02
- 2022-10-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-03 | Pfizer-BioNTech | |
| 2 | 2021-01-24 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
Free text
Release 10 — 3 months, dose 3
Symptoms: Sore throat and cough
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release